|
|
Effect of Ergometrine Maleate Injection in the treatment of postpartum hemorrhage |
LI You-xiang XU Xiao-yuan |
Department of Obstetrics and Gynecology, the Third People′s Hospital of Jingdezhen, Jiangxi Province, Jingdezhen 333001, China |
|
|
Abstract Objective To analyze the clinical effect of Ergometrine Maleate Injection in the treatment of postpartum hemorrhage. Methods A total of 60 patients with postpartum hemorrhage treated in our hospital from June 2018 to June 2019 were selected as research objects, and they were divided into control group and research group according to the random number table method, with 30 cases in each group. Patients in the control group were treated with Oxytocin Injection, and patients in the research group were treated with Oxytocin Injection and Ergometrine Maleate Injection. The therapeutic effect, postpartum hemorrhage volume, blood coagulation indicators (fibrinogen [FIB], prothrombin time[PT], activated partial thrombin time [APTT]) before and after treatment, and incidence of adverse reactions were compared between the two groups of patients. Results The total effective rate of treatment in the research group was 100.00%, which was higher than 73.33% in the control group, and the difference was statistically significant (P<0.05).The postpartum hemorrhage volume at 0.5, 2 and 24 hours in the research group was less than that in the control group, and the difference was statistically significant (P<0.05). After treatment, the FIB levels of the two groups were lower than those before treatment, and PT and APTT were longer than those before treatment, with statistically significant differences (P<0.05). The level of FIB after treatment in the research group was lower than that in the control group, and the PT and APTT were longer than those in the control group, with statistically significant differences (P<0.05). There was no significant difference in the total incidence rate of adverse reactions between the two groups (P>0.05). Conclusion Ergometrine Maleate Injection can effectively reduce postpartum hemorrhage volume and promote recovery of patients, which has the promotion value.
|
|
|
|
|
[1] |
宋小侠,卢燕玲,翁廷松,等.马来酸麦角新碱、卡贝缩宫素及卡前列素氨丁三醇预防和治疗宫缩乏力性产后出血效果的比较[J].广东医学,2017,38(18):2850-2852,2855.
|
[2] |
符静,李倩,刘晓莉.马来酸麦角新碱预防剖宫产产后出血的疗效观察[J].中国实用医药,2019,14(3):92-94.
|
[3] |
韩小雪,潘颖,董南,等.静脉滴注新麦角新碱预防产后出血对血压的影响[J].妇产与遗传(电子版),2018,8(1):23-26.
|
[4] |
冯晓云,韩冰,徐桂冉,等.缩宫素联合马来酸麦角新碱预防宫缩乏力产后出血的疗效及安全性探讨[J].解放军预防医学杂志,2019,37(1):111-113.
|
[5] |
严红梅.马来酸麦角新碱在高危因素剖宫产中的临床应用效果观察[J].临床合理用药杂志,2018,11(32):77-78.
|
[6] |
钟思梅,龚逞英,江春慧,等.马来酸麦角新碱联合缩宫素促进剖宫产术后子宫复旧的临床研究[J].当代医学,2018,24(23):89-91.
|
[7] |
黄君燕.麦角新碱联合缩宫素治疗产后出血的效果[J].实用妇科内分泌杂志(电子版),2018,5(33):64-65.
|
[8] |
蔡怡琦,汤云仙,杨如,等.缩宫素与马来酸麦角新碱预防高危产妇产后出血效果对比[J].中国病案,2018,19(11):100-103.
|
[9] |
张亚萍.三联疗法治疗宫缩乏力性产后出血疗效观察[J].临床医学研究与实践,2017,2(26):126-127.
|
[10] |
陈怡.卡前列素氨丁三醇、麦角新碱、缩宫素三联疗法预防产后出血的临床疗效观察[J].中国妇幼保健,2018,33(6):1266-1268.
|
[11] |
卫蔷,张力,吴琳,等.麦角新碱联合卡贝缩宫素与单用缩宫素预防剖宫产产后出血研究[J].中国实用妇科与产科杂志,2018,34(6):640-644.
|
[12] |
杨晓辉.麦角新碱联合垂体后叶注射液治疗产后出血的疗效观察[J].现代药物与临床,2017,32(5):864-866.
|
[13] |
王翼飞,金玲玲,陈霞.产后即时使用安列克的临床效果观察[J].中国计划生育学杂志,2016,24(4):261-263.
|
[14] |
徐京晶,刘玉凌,查莹,等.马来酸麦角新碱三针法预防瘢痕子宫再次妊娠产后出血的临床观察[J].华中科技大学学报(医学版),2019,48(1):89-92.
|
[15] |
徐淑静.三联法对经产妇宫缩乏力性产后出血的疗效观察[J].实用妇科内分泌杂志(电子版),2018,5(31):93,95.
|
|
|
|